Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, par value, $0.001 per share
-
Shares outstanding
-
50,013,453
-
Number of holders
-
30
-
Total 13F shares, excl. options
-
13,532,500
-
Shares change
-
+11,603,173
-
Total reported value, excl. options
-
$9,178,137
-
Value change
-
+$7,852,763
-
Put/Call ratio
-
0%
-
Number of buys
-
19
-
Number of sells
-
2
-
Price
-
$0.6783
Institutional Holders of NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share (NMTC) as of Q2 2025
As of 30 Jun 2025 NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share (NMTC) had 30 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 13,532,500 shares of stock of the company.
Largest 10 holders included Bleichroeder LP, Sio Capital Management, LLC, BARD ASSOCIATES INC, PERKINS CAPITAL MANAGEMENT INC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, Cambridge Investment Research Advisors, Inc., XTX Topco Ltd, and CITADEL ADVISORS LLC.
This table shows 30 institutional shareholders of the security as of 30 Jun 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.